Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma .Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer ( OPTIMAL , CTONG-0802 ) : a multicentre , open-label , ran ......